Talk:Angiotensin II receptor antagonist

From Wikipedia, the free encyclopedia
Jump to: navigation, search
WikiProject Pharmacology (Rated C-class, Top-importance)
WikiProject icon This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.
C-Class article C  This article has been rated as C-Class on the project's quality scale.
 Top  This article has been rated as Top-importance on the project's importance scale.
 
WikiProject Medicine (Rated C-class, Mid-importance)
WikiProject icon This article is within the scope of WikiProject Medicine, which recommends that this article follow the Manual of Style for medicine-related articles and use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.
C-Class article C  This article has been rated as C-Class on the project's quality scale.
 Mid  This article has been rated as Mid-importance on the project's importance scale.
 

additional side effects[edit]

ARB's have been shown to be teratogenic. http://www.fda.gov/hearthealth/treatments/medications/arbs.html under "pregnancy" category.

66.7.132.30 21:53, 27 August 2007 (UTC)Mko

call it ARB[edit]

shouldn't this article really be changed to Angiotensin Receptor Blocker ? All the world seems to use that term.

Kenmcl2 (talk) 23:03, 4 November 2008 (UTC)

eprosartan[edit]

Eprosartan has to be added (with his link); a wikipedia page of it already exists: http://en.wikipedia.org/wiki/Eprosartan

Comparison of Pharmacokinetics[edit]

The table comparing the drug pharmacokinetics needs looking at or referencing. Most of them are mostly excreted unchanged with little hepatic metabolism, or as I understand it from the MIMS database (database of drug information provided by manufacturer). The numbers aren't the wrong way around either, they're completely different.

On an additional note in regards to an earlier comment, 'Angiotensin II receptor antagonist' is the more correct term for the class of drug. 'Angiotensin receptor blocker' is a bit of a colloquialism like 'beta blocker', which should technically be 'beta-adrenergic receptor antagonist'. —Preceding unsigned comment added by 58.168.42.137 (talk) 06:28, 7 April 2011 (UTC)

Cancer risk[edit]

This addition is troubling. The cited meta-analysis found "(7.2%vs 6.0%, risk ratio [RR] 1.08, 95% CI 1.01-1.15; p=0.016)". A difference this small in a meta-analysis is nearly lost in the experimental error even if the methodology was perfect in all the original studies. Any flaws in methodology could wipe them out. But the real problem is that it looks at one particular endpoint (cancer) while ignoring others (whether stroke, cardiac events, or even lightning strike). The relevant comparison is for all types of M&M, not just one. On a random basis over the ensemble of outcomes, some risks appear to go up while others appear to go down. We can't tell if this RR is anything more than that random effect.LeadSongDog come howl! 13:46, 2 September 2011 (UTC)

Sticky note idea[edit]

I was moving from Wikipedia article to article trying to figure out what effects the different antihypertension drugs have (just the basic types, not specific drug names) and came across "These substances are AT1-receptor antagonists; that is, they block the activation of [angiotensin II AT1 receptors.]" When I clicked the link, I was taken to a general article about all the angiotensin receptors and I had to remember that I was trying to figure out what a blocker of type 2 angiotensin would be doing to it. It's easy to lose track of what you're trying to figure out, especially in a medical series of articles, and when the articles hand you a jargon and don't explain it right there. Since I have to click through, maybe you could help me out with a handy script that pops up a sticky note saying "From angiotensin II blocker article. Sentence: These substances are AT1-receptor antagonists; that is, they block the activation of angiotensin II AT1 receptors. [Back to article]" Or put it at the top or bottom, or side of each page? That would majorly help me keep it straight. Well consider it please. Thanks. -Confused 24.225.67.129 (talk) 14:16, 5 September 2013 (UTC)